MedPath

PFIZER JAPAN INC.

PFIZER JAPAN INC. logo
🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

124

Active:31
Completed:32

Trial Phases

5 Phases

Phase 1:1
Phase 2:8
Phase 3:16
+2 more phases

Drug Approvals

3

NMPA:2
SFDA:1

Drug Approvals

Palbociclib Tablets

Product Name
哌柏西利片
Approval Number
国药准字HJ20220072
Approval Date
Aug 10, 2022
NMPA

Palbociclib Tablets

Product Name
哌柏西利片
Approval Number
国药准字HJ20220071
Approval Date
Aug 10, 2022
NMPA

Clinical Trials

Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials

Phase 3
16 (53.3%)
Phase 2
8 (26.7%)
Not Applicable
3 (10.0%)
Phase 4
2 (6.7%)
Phase 1
1 (3.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.